Applied Finance Capital Management’s Biogen BIIB Stock Holding History

Applied Finance Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Sell	1,324 -518	-28%	-$99.1K	0.02%	186
2026 Q1	$338K	Buy	1,842 +38	+2%	+$7K	0.03%	176
2025 Q4	$317K	Sell	1,804 -1,074	-37%	-$175K	0.02%	187
2025 Q3	$403K	Sell	2,878 -825	-22%	-$112K	0.03%	201
2025 Q2	$465K	Buy	+3,703	New	+$461K	0.03%	205
2024 Q3	–	Sell	-3,362	Closed	-$779K	–	301
2024 Q2	$779K	Buy	+3,362	New	+$731K	0.04%	123

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Applied Finance Capital Management's BIIB Position: Q2 2026 in Review

Applied Finance Capital Management reduced its Biogen (BIIB) stake by 28% in Q2 2026, selling an estimated $99.1K and leaving 1,324 shares worth $286K. The position accounts for 0.02% of the portfolio, ranked #186.

Applied Finance Capital Management first reported a position in BIIB in Q2 2024 and has held it in 6 quarters since. The position peaked at $779K in Q2 2024. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Applied Finance Capital Management held 1,324 shares of Biogen worth $286K as of Q2 2026.
Applied Finance Capital Management sold 518 Biogen shares in Q2 2026, an estimated $99.1K.
Biogen made up 0.02% of Applied Finance Capital Management's portfolio in Q2 2026, its #186 holding.
Applied Finance Capital Management first reported a position in Biogen in Q2 2024 and has held it in 6 quarters since.
Applied Finance Capital Management's Biogen position peaked at $779K in Q2 2024.
1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.